References

  1. Choudhury N. Transfusion transmitted infections: how many more. Asian J Transfus Sci. 2010; 4(2): 71-2. PubMed | Google Scholar

  2. Shrestha AC, Ghimire P, Tiwari BR, Rajkarnikar M. Transfusion-transmissible infections among blood donors in Kathmandu, Nepal. J Infect Dev Ctries. 2009; 3(10): 794-7. PubMed | Google Scholar

  3. Noubiap JJN, Joko WYA, Nansseu JRN, Tene UG, Siaka C. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among first-time blood donors in Edéa, Cameroon. Int J Infect Dis. 2013; 17(10): e832-7. Google Scholar

  4. Buseri FI, Muhibi MA, Jeremiah ZA. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfus Trasfus Sangue. 2009; 7(4): 293-9. PubMed | Google Scholar

  5. Koné MC, Sidibé ET, Mallé KK, Beye SA, Lurton G, Dao S et al. Séroprévalence des virus de l'immunodéficience humaine et des hépatites B et C chez les donneurs de sang à Ségou (Mali). Méd Santé Trop. 2012; 22(1): 97-8. Google Scholar

  6. Mayaki Z, Dardenne N, Kabo R, Moutschen M, Sondag D, Albert A et al. Séroprévalence des marqueurs de l'infection chez les donneurs de sang à Niamey (Niger). Rev Dépidémiologie Santé Pub. 2013; 61(3): 233-40. Google Scholar

  7. Matee MIN, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health. 2006; 6: 21. Google Scholar

  8. Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010; 10: 111. Google Scholar

  9. Nagalo BM, Bisseye C, Sanou M, Kienou K, Nebié YK, Kiba A et al. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa. Trop Med Int Health. 2012; 17(2): 247-53. PubMed | Google Scholar

  10. Batina A, Kabemba S, Malengela R. Infectious markers among blood donors in Democratic Republic of Congo (DRC). Rev Méd Brux. 2007; 28(3): 145-9. PubMed | Google Scholar

  11. Lo BB, Meymouna M, Boulahi MA, Tew M, Sow A, Ba A et al. Prevalence of serum markers of hepatitis B and C virus in blood donors of Nouakchott, Mauritania. Bull Société Pathol Exot. 1999; 92(2): 83-4. PubMed | Google Scholar

  12. Candotti D, Sarkodie F, Allain JP. Residual risk of transfusion in Ghana. Br J Haematol. 2001; 113(1): 37-9. PubMed | Google Scholar

  13. Ayé MO, Moktar MM. Épidémiologie de l'hépatite C en Mauritanie. J Afr Hépato-Gastro. 2008; 1(3-4): 141-2. Google Scholar

  14. Mansour W, Bollahi M-A, Hamed C-T, Brichler S, Le Gal F, Ducancelle A et al. Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania. J Clin Virol. 2012; 55(1): 12-6. PubMed | Google Scholar

  15. Tagny CT, Owusu-Ofori S, Mbanya D, Deneys V. The blood donor in sub-Saharan Africa: a review. Transfus Med Oxf Engl. 2010; 20(1): 1-10. PubMed | Google Scholar

  16. Kra O, N'Dri N, Ehui E, Ouattara B, Bissagnene E. Prevalence of HBs antigen in blood donors in the Bouaké regional centre of blood transfusion in 2001. Bull Société Pathol Exot. 2007; 100(2): 127-9. PubMed | Google Scholar

  17. Moukoko CEE, Sack FN, Same EGE, Mbangue M, Lehman LG, HIV, HBV, HCV and T. pallidum infections among blood donors and Transfusion-related complications among recipients at the Laquintinie hospital in Douala, Cameroon. BMC Hematol. 12 2014; 14(1): 5. Google Scholar

  18. Nzaji MK, Ilunga BK. A study of the prevalence of infectious markers in blood donors in rural areas: the case of Kamina hospital. Santé Pub. 2013; 25(2): 213-7. PubMed | Google Scholar

  19. Bisseye C, Sanou M, Nagalo BM, Kiba A, Compaoré TR, Tao I et al. Epidemiology of Syphilis in regional blood transfusion centres in Burkina Faso, West Africa. Pan Afr Med J. 2013; 16: 69. PubMed | Google Scholar

  20. Diarra A, Kouriba B, Baby M, Murphy E, Lefrere J-J. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors. Transfus Clin Biol J Société Fr Transfus Sang. 2009; 16(5-6): 444-7. PubMed | Google Scholar

  21. Vray M, Debonne J-M, Sire J-M, Tran N, Chevalier B, Plantier J-C et al. Molecular epidemiology of hepatitis B virus in Dakar, Sénégal. J Med Virol. 2006; 78(3): 329-34. PubMed | Google Scholar

  22. Baha W, Foullous A, Dersi N, They-they TP, El alaoui K, Nourichafi N et al. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health. 2013; 13: 50. PubMed | Google Scholar

  23. Dieye TN, Gadji M, Cisse Y, Diallo TA, Toure Falla O, Diop S et al. Seroprevalence of hepatitis C virus (HCV) in Senegalease blood donors. Dakar Méd. 2006; 51(1): 47-52. PubMed | Google Scholar

  24. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis. 2013 June 24; 13: 288. PubMed | Google Scholar

  25. Abid S, Fkih S, Khlass B, Cherif W, Toumi NH, Jenhani F et al. Screening and confirmation of anti-HCV antibodies in Tunisian blood donors. Transfus Clin Biol J. 1997; 4(2): 221-6. PubMed | Google Scholar

  26. Ayed Z, Houinato D, Hocine M, Ranger-Rogez S, Denis F. Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria. Bull Société Pathol Exot 1990. 1995; 88(5): 225-8. PubMed | Google Scholar

  27. Fall-Malick FZ, Bara AO, Lam M, Mint Beibacar M, Ba K, Ba H et al. HIV sentinel surveillance of pregnant women in Mauritania from 2001 to 2007. Bull Société Pathol Exot 1990. 2010; 103(4): 243-5. PubMed | Google Scholar

  28. Elmir E, Nadia S, Ouafae B, Rajae M, Amina S, Rajae EA. HIV epidemiology in Morocco: a nine-year survey (1991-1999). Int J STD AIDS. 2002; 13(12): 839-42. PubMed | Google Scholar

  29. Ait-Kaki1 B, Belabes E, Bouguermouh A, Aouati A, Smati1 F. Aspects seroepidemiologiques de l'infection a VIH en Algérie. Sci Technol C. 2004; 22: 7-10. Google Scholar

  30. Iroezindu MO, Daniyam CA, Agbaji OO, Isa ES, Okeke EN, Imade GE. Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria. J Infect Dev Ctries. 2013 Dec 15; 7(12): 951-9. PubMed | Google Scholar

  31. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995; 346(8974): 530-6. PubMed | Google Scholar